focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,812.50
Bid: 1,812.50
Ask: 1,813.00
Change: 2.50 (0.14%)
Spread: 0.50 (0.028%)
Open: 1,811.00
High: 1,820.00
Low: 1,803.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stock markets flat ahead of quiet day

Fri, 13th Mar 2015 09:06

UK stocks were more or less flat in early deals on Friday ahead of a quiet day for the markets in terms of economic data and corporate news.London's FTSE 100 was trading up just 0.01% at 6,761.79 early on.As it stands, the Footsie is still nearly 3% lower than where it stood last Friday as a strengthening pound and weak Chinese data weighed on commodity prices, while ongoing concerns about Greek continued to hit sentiment.Friday is set to be a quiet day in terms of economic data, with UK construction output, the US producer price index (PPI) and University of Michigan (UoM) consumer confidence survey the only major indicators being released."The PPI reading can be a good indicator of future inflation so is worth tracking, while the UoM reading could give some insight into consumer spending expectations ahead of the summer," said analyst Craig Erlam from Oanda.Afren plunges on recapitalisation planShares in Afren tumbled after the struggling oil and gas group proposed a debt-for-equity swap with creditors to address its funding needs and recapitalise its capital structure. The company said it "will result in substantial dilution for existing shareholders", and if shareholders don't approve the plan, the company will have no choice but to initiate a sale.Glasxosmithkline edged lower after selling half its stake in former South African associate Aspen Pharmacare for £0.57bn. Having sold 28.2m shares, at a price of 372 rand per share, GSK now holds a 6.2% stake in Aspen, South Africa's largest drug company.JD Wetherspoon served up a slightly short measure of first-half profits as the pubs group saw cost pressures outweigh a rise in revenues. Profits declined 0.9% in the first half while the interim dividend was maintained, causing shares to fall in London.Costa and Premier Inn owner Whitbread was racking up gains after UBS upgraded the stock to 'neutral' and Deustche Bank raised it to 'buy', while spirits group Diageo was lower after a downgrade by Credit Suisse to 'underperform'.Market MoverstechMARK 3,177.56 +0.33%FTSE 100 6,761.79 +0.01%FTSE 250 17,109.41 +0.28%FTSE 100 - RisersWhitbread (WTB) 5,400.00p +2.66%ARM Holdings (ARM) 1,180.00p +1.55%Meggitt (MGGT) 568.00p +1.52%Wolseley (WOS) 4,110.00p +1.46%British Land Co (BLND) 816.00p +1.37%Antofagasta (ANTO) 709.00p +1.21%GKN (GKN) 366.30p +1.19%Carnival (CCL) 3,132.00p +1.13%Fresnillo (FRES) 660.50p +1.07%Land Securities Group (LAND) 1,210.00p +1.00%FTSE 100 - FallersDiageo (DGE) 1,850.00p -1.70%SSE (SSE) 1,471.00p -1.34%Travis Perkins (TPK) 1,942.00p -1.27%Centrica (CNA) 238.60p -1.16%BG Group (BG.) 829.20p -1.12%Smiths Group (SMIN) 1,153.00p -1.11%BP (BP.) 421.95p -0.92%Sage Group (SGE) 472.40p -0.92%BHP Billiton (BLT) 1,424.00p -0.80%Ashtead Group (AHT) 1,107.00p -0.54%FTSE 250 - RisersThomas Cook Group (TCG) 155.10p +4.37%St. Modwen Properties (SMP) 454.50p +2.83%Bwin.party Digital Entertainment (BPTY) 81.75p +2.64%Allied Minds (ALM) 635.00p +2.50%Ladbrokes (LAD) 114.10p +2.33%Just Eat (JE.) 340.00p +2.22%Just Retirement Group (JRG) 155.20p +2.11%Workspace Group (WKP) 829.50p +2.09%Intermediate Capital Group (ICP) 483.80p +2.07%Grafton Group Units (GFTU) 780.00p +2.03%FTSE 250 - FallersAfren (AFR) 5.50p -15.38%Cairn Energy (CNE) 155.70p -3.41%Soco International (SIA) 153.40p -3.28%Wetherspoon (J.D.) (JDW) 785.00p -3.27%Hikma Pharmaceuticals (HIK) 2,288.00p -2.84%Lonmin (LMI) 107.90p -2.53%Vedanta Resources (VED) 514.50p -2.46%Cranswick (CWK) 1,378.00p -2.20%Premier Oil (PMO) 134.60p -1.97%Spire Healthcare Group (SPI) 323.70p -1.91%
More News
25 Sep 2023 08:37

TOP NEWS: GSK's Arexvy vaccine approved for adults over 60 in Japan

(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60.

Read more
25 Sep 2023 07:28

GSK's RSV vaccine gets approval in Japan

(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.

Read more
19 Sep 2023 09:30

GSK says new HIV PrEP medication authorised by European Commission

(Alliance News) - GSK PLC on Tuesday said the European Commission has authorised ViiV Healthcare's "superior" drug Apretude to reduce the risk of sexually acquired HIV-1 infection.

Read more
18 Sep 2023 09:40

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
18 Sep 2023 07:57

LONDON BRIEFING: Phoenix Group hails "impressive" first-half

(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.

Read more
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more
1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.